New study aims to unlock recovery secrets of rare immunotherapy heart side effect
NCT ID NCT07278817
First seen Jan 04, 2026 · Last updated Apr 25, 2026 · Updated 19 times
Summary
This study will follow 340 people who have recovered from a rare but serious heart condition caused by immune checkpoint inhibitors (a type of cancer immunotherapy). The goal is to learn more about their health and recovery by combining insights from both Western and Traditional Chinese Medicine. Participants will be monitored for major heart events and their quality of life will be tracked over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.